The pharma and biotech CRM software market is segmented by technology into artificial intelligence customer relationship management (CRM) and conventional customer relationship management (CRM). The conventional customer relationship management (CRM) market was the largest segment of the pharma and biotech CRM software market segmented by technology, accounting for 81.95% or $3.55 billion of the total in 2024. Going forward, the artificial intelligence customer relationship management (CRM) segment is expected to be the fastest growing segment in the pharma and biotech CRM software market segmented by technology, at a CAGR of 14.60% during 2024-2029.
The pharma and biotech CRM software market is segmented by deployment into on-premises and cloud-based. The cloud-based market was the largest segment of the pharma and biotech CRM software market segmented by deployment, accounting for 61.82% or $2.68 billion of the total in 2024. Going forward, the cloud-based segment is expected to be the fastest growing segment in the pharma and biotech CRM software market segmented by deployment, at a CAGR of 9.91% during 2024-2029.
The pharma and biotech CRM software market is segmented by enterprise size into large enterprises and small and medium enterprises (SMEs). The large enterprises market was the largest segment of the pharma and biotech CRM software market segmented by enterprise size, accounting for 62.22% or $2.69 billion of the total in 2024. Going forward, the small and medium enterprises (SMEs) segment is expected to be the fastest growing segment in the pharma and biotech CRM software market segmented by enterprise size, at a CAGR of 11.00% during 2024-2029.
The pharma and biotech CRM software market is segmented by industry into pharmaceuticals and biotech. The pharmaceuticals market was the largest segment of the pharma and biotech CRM software market segmented by industry, accounting for 68.10% or $2.95 billion of the total in 2024. Going forward, the biotech segment is expected to be the fastest growing segment in the pharma and biotech CRM software market segmented by industry, at a CAGR of 10.64% during 2024-2029.
North America was the largest region in the pharma and biotech CRM software market, accounting for 36.24% or $1.57 billion of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the pharma and biotech CRM software market will be Asia Pacific and Middle East where growth will be at CAGRs of 10.02% and 9.53% respectively. These will be followed by South America and Eastern Europe where the markets are expected to grow at CAGRs of 8.87% and 8.50% respectively.
The global pharma and biotech CRM software market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 94.96% of the total market in 2023. Veeva Systems Inc was the largest competitor with a 26.81% share of the market, followed by IQVIA Holdings Inc with 17.73%, Salesforce.com Inc with 16.40%, Oracle Corporation with 11.21%, SAP SE with 5.17%, Microsoft Corporation with 4.90%, Zoho Corporation Pvt. Ltd with 4.08%, Pega Systems Inc with 3.61%, HubSpot Inc with 2.68% and Indegene Private Limited with 2.39%.
The top opportunities in the pharma and biotech CRM software market segmented by technology will arise in the conventional customer relationship management (CRM) segment, which will gain $1.45 billion of global annual sales by 2029. The top opportunities in the pharma and biotech CRM software market segmented by deployment will arise in the cloud-based segment, which will gain $1.62 billion of global annual sales by 2029. The top opportunities in the pharma and biotech CRM software market segmented by enterprise size will arise in the small and medium enterprises (SMEs) segment, which will gain $1.12 billion of global annual sales by 2029. The top opportunities in the pharma and biotech CRM software market segmented by industry will arise in the pharma segment, which will gain $1.3 billion of global annual sales by 2029. The pharma and biotech CRM software market size will gain the most in the USA at $553.92 million.
This report describes and explains the pharma and biotech CRM software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global pharma and biotech CRM software market reached a value of nearly $4.33 billion in 2024, having grown at a compound annual growth rate (CAGR) of 9.15% since 2019. The market is expected to grow from $4.33 billion in 2024 to $6.55 billion in 2029 at a rate of 8.60%. The market is then expected to grow at a CAGR of 8.49% from 2029 and reach $9.85 billion in 2034.
Growth in the historic period resulted from the expansion of telemedicine and remote healthcare, growth in clinical trial activities, rising healthcare expenditure and growing demand for cloud-based solutions. Factors that negatively affected growth in the historic period were complex regulatory challenges and security and data privacy concerns.
Going forward, the rise in chronic diseases, increasing client engagement activities, expanding global pharmaceutical sales force and favorable government initiatives will drive the growth. Factor that could hinder the growth of the pharma and biotech CRM software market in the future include resistance to digital adoption, talent shortages and impact of trade war and tariff.
Market-trend-based strategies for the pharma and biotech CRM software market include focus on integrating electronic health records into pharma CRM systems, focus on strategic partnerships driving innovation in pharma and biotech CRM software and focus on voice-controlled CRM interfaces boosting productivity in pharma sales.
Player-adopted strategies in the pharma and biotech CRM software market include focus on strategic partnerships to better serve the industry and to strengthen their position and focus on expanding operational capabilities through new launches.
To take advantage of the opportunities, the analyst recommends the pharma and biotech CRM software market companies to focus on AI-driven personalization for stakeholder engagement, focus on generative AI integration to enhance CRM functionality, focus on artificial intelligence CRM for high-growth opportunities, focus on cloud-based CRM solutions to maximize growth, expand in emerging markets, continue to focus on developed markets, focus on optimizing multichannel distribution networks, focus on tiered pricing aligned with company size and compliance needs, focus on physician-centric promotional channels, focus on omnichannel digital campaigns and focus on customizing CRM engagement for biotech stakeholders.
This product will be delivered within 3-5 business days.
The pharma and biotech CRM software market is segmented by deployment into on-premises and cloud-based. The cloud-based market was the largest segment of the pharma and biotech CRM software market segmented by deployment, accounting for 61.82% or $2.68 billion of the total in 2024. Going forward, the cloud-based segment is expected to be the fastest growing segment in the pharma and biotech CRM software market segmented by deployment, at a CAGR of 9.91% during 2024-2029.
The pharma and biotech CRM software market is segmented by enterprise size into large enterprises and small and medium enterprises (SMEs). The large enterprises market was the largest segment of the pharma and biotech CRM software market segmented by enterprise size, accounting for 62.22% or $2.69 billion of the total in 2024. Going forward, the small and medium enterprises (SMEs) segment is expected to be the fastest growing segment in the pharma and biotech CRM software market segmented by enterprise size, at a CAGR of 11.00% during 2024-2029.
The pharma and biotech CRM software market is segmented by industry into pharmaceuticals and biotech. The pharmaceuticals market was the largest segment of the pharma and biotech CRM software market segmented by industry, accounting for 68.10% or $2.95 billion of the total in 2024. Going forward, the biotech segment is expected to be the fastest growing segment in the pharma and biotech CRM software market segmented by industry, at a CAGR of 10.64% during 2024-2029.
North America was the largest region in the pharma and biotech CRM software market, accounting for 36.24% or $1.57 billion of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the pharma and biotech CRM software market will be Asia Pacific and Middle East where growth will be at CAGRs of 10.02% and 9.53% respectively. These will be followed by South America and Eastern Europe where the markets are expected to grow at CAGRs of 8.87% and 8.50% respectively.
The global pharma and biotech CRM software market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 94.96% of the total market in 2023. Veeva Systems Inc was the largest competitor with a 26.81% share of the market, followed by IQVIA Holdings Inc with 17.73%, Salesforce.com Inc with 16.40%, Oracle Corporation with 11.21%, SAP SE with 5.17%, Microsoft Corporation with 4.90%, Zoho Corporation Pvt. Ltd with 4.08%, Pega Systems Inc with 3.61%, HubSpot Inc with 2.68% and Indegene Private Limited with 2.39%.
The top opportunities in the pharma and biotech CRM software market segmented by technology will arise in the conventional customer relationship management (CRM) segment, which will gain $1.45 billion of global annual sales by 2029. The top opportunities in the pharma and biotech CRM software market segmented by deployment will arise in the cloud-based segment, which will gain $1.62 billion of global annual sales by 2029. The top opportunities in the pharma and biotech CRM software market segmented by enterprise size will arise in the small and medium enterprises (SMEs) segment, which will gain $1.12 billion of global annual sales by 2029. The top opportunities in the pharma and biotech CRM software market segmented by industry will arise in the pharma segment, which will gain $1.3 billion of global annual sales by 2029. The pharma and biotech CRM software market size will gain the most in the USA at $553.92 million.
This report describes and explains the pharma and biotech CRM software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global pharma and biotech CRM software market reached a value of nearly $4.33 billion in 2024, having grown at a compound annual growth rate (CAGR) of 9.15% since 2019. The market is expected to grow from $4.33 billion in 2024 to $6.55 billion in 2029 at a rate of 8.60%. The market is then expected to grow at a CAGR of 8.49% from 2029 and reach $9.85 billion in 2034.
Growth in the historic period resulted from the expansion of telemedicine and remote healthcare, growth in clinical trial activities, rising healthcare expenditure and growing demand for cloud-based solutions. Factors that negatively affected growth in the historic period were complex regulatory challenges and security and data privacy concerns.
Going forward, the rise in chronic diseases, increasing client engagement activities, expanding global pharmaceutical sales force and favorable government initiatives will drive the growth. Factor that could hinder the growth of the pharma and biotech CRM software market in the future include resistance to digital adoption, talent shortages and impact of trade war and tariff.
Market-trend-based strategies for the pharma and biotech CRM software market include focus on integrating electronic health records into pharma CRM systems, focus on strategic partnerships driving innovation in pharma and biotech CRM software and focus on voice-controlled CRM interfaces boosting productivity in pharma sales.
Player-adopted strategies in the pharma and biotech CRM software market include focus on strategic partnerships to better serve the industry and to strengthen their position and focus on expanding operational capabilities through new launches.
To take advantage of the opportunities, the analyst recommends the pharma and biotech CRM software market companies to focus on AI-driven personalization for stakeholder engagement, focus on generative AI integration to enhance CRM functionality, focus on artificial intelligence CRM for high-growth opportunities, focus on cloud-based CRM solutions to maximize growth, expand in emerging markets, continue to focus on developed markets, focus on optimizing multichannel distribution networks, focus on tiered pricing aligned with company size and compliance needs, focus on physician-centric promotional channels, focus on omnichannel digital campaigns and focus on customizing CRM engagement for biotech stakeholders.
This product will be delivered within 3-5 business days.
Table of Contents
1 Executive Summary
6 Market Characteristics
7 Major Market Trends
8 Global Pharma And Biotech CRM Software Growth Analysis And Strategic Analysis Framework
9 Global Pharma And Biotech CRM Software Market Segmentation
10 Pharma And Biotech CRM Software Market, Regional and Country Analysis
11 Asia-Pacific Market
12 Western Europe Market
13 Eastern Europe Market
14 North America Market
15 South America Market
16 Middle East Market
17 Africa Market
18 Competitive Landscape And Company Profiles
19 Other Major And Innovative Companies
22 Key Mergers And Acquisitions
23 Recent Developments In Pharma And Biotech CRM Software Market
24 Opportunities And Strategies
25 Pharma And Biotech CRM Software Market, Conclusions And Recommendations
26 Appendix
Executive Summary
Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034 provides the strategists; marketers and senior management with the critical information they need to assess the global pharma and biotech CRM software market as it emerges from the COVID-19 shut down.Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for pharma and biotech CRM software? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharma and biotech CRM software market global report answers all these questions and many more.The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider pharma and biotech CRM software market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by deployment, by enterprise size and by industry.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis And Strategic Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by technology, by deployment, by enterprise size and by industry in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report.This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Recent Developments- Information on recent developments in the market covered in the report.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for pharma and biotech CRM software providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Technology: Artificial Intelligence Customer Relationship Management (CRM); Conventional Customer Relationship Management (CRM)2) By Deployment: On-Premise; Cloud-Based
3) By Enterprise Size: Large Enterprises; Small And Medium Enterprises (SMEs)
4) By Industry: Pharmaceuticals; Biotech
Key Companies Profiled: Veeva Systems Inc.; IQVIA Holdings Inc.; Salesforce.com Inc.; Oracle Corporation; SAP SE
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions:Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharma and biotech CRM software indicators comparison.
Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- Veeva Systems Inc.
- IQVIA Holdings Inc.
- Salesforce.com Inc.
- Oracle Corporation
- SAP SE
- Microsoft Corporation
- Zoho Corporation Pvt. Ltd.
- Pega Systems Inc.
- HubSpot Inc.
- Indegene Private Limited
- Yidu Tech Inc.
- Tata Consultancy Services (TCS)
- CitiusTech
- SATORI Inc.
- NTT Data
- Samsung SDS
- Biocodex
- GlaxoSmithKline Plc
- AstraZeneca Plc
- Accord Healthcare Ltd.
- ASKA Biotech GmbH
- KBI Biopharma Inc
- Pharmaserv
- OceanMD
- Phyzii Pharma CRM
- SANeForce
- Novatek International
- Exeevo
- Netclues
- Creatio
- StayinFront
- Alephoo
- Media-Soft Inc.
- Proxima Cloud CRM
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 330 |
| Published | September 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 4.33 Billion |
| Forecasted Market Value ( USD | $ 9.85 Billion |
| Compound Annual Growth Rate | 8.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 34 |
